kimberly-clark kenvue

Kimberly-Clark bets $40 billion on Kenvue

Could Huggies and Tylenol be a good fit? Kimberly-Clark is buying Kenvue for $48 billion

Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ending months of speculation about the future of the embattled maker of Tylenol, Band-Aid and Listerine.

· 2h

Kimberly-Clark: Can The Kenvue Acquisition Erase The Decade Of Disappointment?

· 16h · on MSN

Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue

· 20h

Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue (KVUE.N) in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the Uni...

· 22h

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

· 1d

Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal, creating a massive consumer health goods company

1don MSN

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

18hon MSN

These Stocks Are Moving the Most Today: Kenvue, Kimberly-Clark, Amazon, uniQure, Palantir, Idexx, Cipher Mining, and More

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

1don MSN

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.

5don MSN

Kimberly-Clark Profit Falls, Organic Sales Rise

Kimberly-Clark’s third-quarter profit fell 51% as a result of divestitures, business exits and recent tariffs, although sales ticked up slightly.